Search results
Strong Trial Results For Pfizer Lung Cancer Drug
International Business Times· 6 days agoRoughly half received lorlatinib while the rest received crizotinib, an earlier generation drug. After five years of follow-up time, more than half of...
Arrivent Biopharma enters into cancer drug development collaboration valued at up to $615M -...
The Business Journals· 21 hours agoArriVent, based in Newtown Square, will team with Jiangsu Alphamab Biopharmaceutical to discover and...
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival
Reuters via AOL· 6 days ago(Reuters) -Gilead Sciences' Trodelvy failed to improve survival for patients with advanced bladder ...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga· 2 days agoOn Friday, Pfizer Inc PFE revealed its drug for an advanced form of lung cancer showed promising...
Strong trial results for Pfizer lung cancer drug
Medical Xpress· 6 days agoRoughly half received lorlatinib while the rest received crizotinib, an earlier generation drug. After five years of follow-up time, more than half of...
Strong trial results for Pfizer lung cancer drug
Fox Bangor· 6 days agoA Pfizer medicine has been shown to greatly reduce cancer progression and improve survival outcomes for people in the advanced stages of a form of lung ...
Rep. Sheila Jackson Lee reveals she's been diagnosed with pancreatic cancer. Here's what to know...
Yahoo Life· 3 days agocancer? It’s the 10th most common form of cancer in the United States, according to the Pancreatic ...
Summit Therapeutics’ stock surges as lung-cancer treatment vies with Merck’s blockbuster
Market Watch· 7 days agoInc.’s blockbuster Keytruda in a late-stage clinical trial. The trial compared the Summit drug,...
Researchers identify a key metabolic gene as target for improved cancer immunotherapy
Medical Xpress· 2 hours agoDespite the high response rates with prolonged survival in subsets of melanoma, lung, and renal cancer patients, ICB struggles to show clinical benefit ...
EMA Panel Nods to Seven New Cancer Drugs
Medscape· 6 days agoThe drugs include an anti–PD-L1 monoclonal antibody, a biosimilar, and five generics, with indications covering a wide spectrum of cancers.